New Jersey Jury Awards $12.89 Million in Accutane IBD Verdict
A New Jersey jury has awarded three persons combined compensatory damages of $12.89 million in an Accutane lawsuit against pharmaceutical company Hoffman La-Roche for its failure to adequately inform them of the dangerous side effects of its popular anti-acne medication, Accutane. The verdict by the Atlantic City, NJ jury was only the most recent in a string of judgments against Hoffman La-Roche in courts in other states, over allegations that the anti-acne drug had caused severe bowel maladies that persisted even after discontinuation of the drug.
The three plaintiffs, Kelly Mace, Jordan Speisman, and Lance Sager, all Florida residents, began taking Accutane about a decade ago for treatment of acne. They were in their teens, and the drug had been prescribed to them by their doctors. Soon after, the three began to experience symptoms of Irritable Bowel Disease (IBD) that soon flared into full fledged forms of the condition, including Ulcerative Colitis, and Crohn's Disease. Speisman will soon undergo surgery to remove his colon, while Sager and Mace will need to continue drug therapy to control their symptoms for the rest of their lives. Worse, all three are faced with a life that has an increased risk of colon cancer.
Continue Reading...